On January 15, 2025, Haisco Pharmaceutical Group Co., Ltd announced that it held its first extraordinary general meeting of shareholders, on January 15, 2025, and declared voting results. Accordingly, the shareholder proposal regarding Proposal on the Overall Completion of Fundraising Investment Projects and Subsequent Arrangements for Surplus Funds was approved by the shareholders.